Study Design
The Pharmacogenetics for Individualized Tricyclic Antidepressant (PITA) dosing study was a multicenter RCT in which patients were enrolled between June 1, 2018, and January 1, 2022. The trial protocol is provided in The participating institutions were hospitals and mental health care institutions in the Netherlands (eTable 1 in 